There was a problem adding this course to your account. Please try again in a few minutes. If the problem persists, you can contact our support department at (877) 880-1335.
Adding Registration, Please wait...
You must be logged in to perform this action.
Log in
Cancel
Cervical Cancer Prevention: An Update on New Screening and Risk-Based Management Guidelines
July 15, 2026 (11:55 p.m. CT) CE for this activity will not be available after this date.
This CE activity was recorded for the 2025 AANP National Conference.
This activity includes closed captioning.
Delivery Note: The content for this activity was previously presented during the 2025 AANP National Conference. If you already completed the content of this activity while attending the live or virtual conference, you should not complete this content a second time. Learners should only complete ONE delivery-method to earn credit. Completing multiple delivery options for the same activity is considered duplicate credit for the same content and will not be accepted by regulatory bodies.
Overview Cervical cancer prevention has changed significantly in recent years with less frequent screening and with the approval of HPV primary screening every 5 years, with a reflex Pap done only if the HPV test is positive. Additionally, cotesting with Pap and HPV every 5 years or Pap alone every 3 years remains an option. This session will review the appropriate use of Pap testing, the rationale for HPV testing along with the Pap (co-testing) in women 30 and older and the use of HPV testing as a primary screen (stand-alone test) in women 25 and older by two of the FDA approved HPV tests. There will be a discussion of the American Cancer Society Guidelines for screening and a review of the 2019 ASCCP Risk-Based Management Consensus Guidelines for management of abnormal screening and subsequent follow-up with case studies. These guidelines are a shift from results-based to risk-based management relative to the risk of an existing CIN 3 (pre-cancer).
Objectives
Describe the role of persistent oncogenic HPV in the development of pre-cancer and cancer of the cervix.
List two different uses of HPV testing in cervical cancer screening including co-testing and HPV testing as primary stand-alone screening.
Understand how HPV epidemiology drives risk-based cancer prevention.
Understand why risk-based management represents an improvement in care.
Describe the fundamentals of risk-based guidelines for managing patients.
Speaker Nancy R. Berman MSN, ANP-BC, MSCP, FAANP Disclosure This program was planned in accordance with AANP CE Standards and Policies. The speaker has the following disclosures:
I was on the advisory board for Astellas for a non-hormonal treatment for vasomotor symptoms.
I am a speaker for Astellas for a non-hormonal treatment of vasomotor symptoms.
All relevant financial relationships have been mitigated.
Disclaimer Individuals who have contributed to the CE Center (content originally from the 2025 AANP National Conference) were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete all educational content:
OnDemand Presentations: Click the Play button to watch the activity video lecture. To get full credit for the learning activity portion, you must watch all of the video content.
Click on the Additional Resources button to review all additional materials provided (handouts and any other downloadable resources).
After completing all educational content, go to the Next Steps button:
Submit the activity evaluation to receive full AANP CE/Rx credit.
Click on the Get Certificate button. At the top of the certificate screen, use the provided dropdown menu and select AANP Certificate of Completion.
A copy of your certificate of completion will display on the screen for you to print or save. A copy of the certificate will also be emailed to you.
A copy of the certificate will be automatically added to your AANP CE Tracker.
Additional Information For questions or more information concerning this online CE activity,please visit the AANP Help Center to find answers to frequently asked questions and request assistance.
0.92 Contact Hour(s) of CE
Additional CE activities of interest
(OnDemand) What To Do First with Type 2 Diabetes
(OnDemand) A Systematic Approach to the Diagnosis and Management of Abnormal Uterine Bleeding
(OnDemand) Common GI Complaints
(OnDemand) Hormones for Vasomotor Symptoms of Menopause: A Primer for the Primary Care Providers
(OnDemand) Breast Abscess and Breast Pain
(OnDemand) Cancer Screening 2025
(OnDemand) Obesity and Menopause: Improving Outcomes
(OnDemand) A Focus on Men’s Health: Erectile Dysfunction and Testosterone Deficiency
(OnDemand) Osteoporosis Management and Fracture Prevention
(OnDemand) Headaches: Everything but Migraine
(OnDemand) Nuts and Bolts of Hypothyroid Disease in Primary Care
Adding Registration, Please wait...
